Astal Laboratories schedules 33rd AGM for September 29, 2026
- Astal Laboratories schedules its 33rd AGM for September 29, 2026
- Remote e-voting window opens on September 26 and closes on September 28
- Board approved FY26 financial results in September 4 meeting
- Share transfer books close from September 23 to September 29

*this image is generated using AI for illustrative purposes only.
Astal Laboratories has scheduled its 33rd Annual General Meeting for September 29, 2026. The meeting will be held via video conference or other audio-visual means.
The company confirmed that shareholders can cast their votes electronically between September 26 and September 28, 2026. The board previously approved the financial results for FY26 during its session on September 4, 2026.
Key Outcomes
The board approved several key governance and compliance items during its session.
| Agenda Item | Status / Details |
|---|---|
| Financial Results | Approved for FY ended March 31, 2026 |
| Cost Auditor | M/s Avnesh Jain & Co. appointed for FY27 |
| AGM Date | September 29, 2026, at 1:30 pm |
| Voting Mode | Video Conferencing / OAVM |
| Scrutinizer | M/s Mahendra Khandelwal & Co. appointed |
E-Voting Schedule
Shareholders eligible to vote must be on the register of members as of the cut-off date, Tuesday, September 22, 2026. The remote e-voting process begins on Saturday, September 26, 2026, at 9:00 am and concludes on Monday, September 28, 2026, at 5:00 pm.
AGM Logistics
The 33rd Annual General Meeting is scheduled for Tuesday, September 29, 2026, at 1:30 pm. The register of members and share transfer books will remain closed from Wednesday, September 23, 2026, to Tuesday, September 29, 2026.
M/s Mahendra Khandelwal & Co., Practicing Company Secretary, was appointed as the scrutinizer to oversee remote e-voting and e-voting during the AGM.
The disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Historical Stock Returns for Astal Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.31% | -4.50% | -14.32% | -3.94% | -14.06% | 0.0% |
What key strategic initiatives or capital allocation plans is Astal Laboratories' management expected to announce or discuss at the AGM that could impact shareholder value?
How have Astal Laboratories' FY26 financial results compared to industry peers, and what does this signal about the company's competitive positioning going into FY27?
Will the appointment of M/s Avnesh Jain & Co. as Cost Auditor for FY27 lead to any significant changes in the company's cost structure or operational efficiency strategies?
































